Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.0806542 on October 4, 2006

Published online before print October 4, 2006
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
jlb.0806542v1
81/1/137    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rittirsch, D.
Right arrow Articles by Ward, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rittirsch, D.
Right arrow Articles by Ward, P. A.
(Journal of Leukocyte Biology. 2007;81:137-143.)
© 2007 by Society for Leukocyte Biology

The disconnect between animal models of sepsis and human sepsis

Daniel Rittirsch, L. Marco Hoesel and Peter A. Ward1

Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA

1Correspondence: Department of Pathology, University of Michigan Medical School, 1301 Catherine Road, Ann Arbor, MI 48109-0602, USA. E-mail: pward{at}umich.edu

Frequently used experimental models of sepsis include cecal ligation and puncture, ascending colon stent peritonitis, and the i.p. or i.v. injection of bacteria or bacterial products (such as LPS). Many of these models mimic the pathophysiology of human sepsis. However, identification of mediators in animals, the blockade of which has been protective, has not translated into clinical efficacy in septic humans. We describe the shortcomings of the animal models and reasons why effective therapy for human sepsis cannot be derived readily from promising findings in animal sepsis.

Key Words: cecal ligation and puncture • lipopolysaccharide • rodents




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Inoue, J. Unsinger, C. G. Davis, J. T. Muenzer, T. A. Ferguson, K. Chang, D. F. Osborne, A. T. Clark, C. M. Coopersmith, J. E. McDunn, et al.
IL-15 Prevents Apoptosis, Reverses Innate and Adaptive Immune Dysfunction, and Improves Survival in Sepsis
J. Immunol., February 1, 2010; 184(3): 1401 - 1409.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. M. Piliponsky, C.-C. Chen, M. A. Grimbaldeston, S. M. Burns-Guydish, J. Hardy, J. Kalesnikoff, C. H. Contag, M. Tsai, and S. J. Galli
Mast Cell-Derived TNF Can Exacerbate Mortality during Severe Bacterial Infections in C57BL/6-KitW-sh/W-sh Mice
Am. J. Pathol., February 1, 2010; 176(2): 926 - 938.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Rodriguez, A. Chora, B. Goumnerov, C. Mumaw, W. S. Goebel, L. Fernandez, H. Baydoun, H. HogenEsch, D. M. Dombkowski, C. A. Karlewicz, et al.
Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis
Blood, November 5, 2009; 114(19): 4064 - 4076.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
C. Jennings, B. Kusler, and P. P. Jones
Calcineurin inactivation leads to decreased responsiveness to LPS in macrophages and dendritic cells and protects against LPS-induced toxicity in vivo
Innate Immunity, April 1, 2009; 15(2): 109 - 120.
[Abstract] [PDF]


Home page
FASEB J.Home page
M. A. Flierl, D. Rittirsch, B. A. Nadeau, D. E. Day, F. S. Zetoune, J. V. Sarma, M. S. Huber-Lang, and P. A. Ward
Functions of the complement components C3 and C5 during sepsis
FASEB J, October 1, 2008; 22(10): 3483 - 3490.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Chorny, P. Anderson, E. Gonzalez-Rey, and M. Delgado
Ghrelin Protects against Experimental Sepsis by Inhibiting High-Mobility Group Box 1 Release and by Killing Bacteria
J. Immunol., June 15, 2008; 180(12): 8369 - 8377.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. Plitas, B. M. Burt, H. M. Nguyen, Z. M. Bamboat, and R. P. DeMatteo
Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis
J. Exp. Med., June 9, 2008; 205(6): 1277 - 1283.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. A. Fowler, N. K. J. Adhikari, D. C. Scales, W. L. Lee, and G. D. Rubenfeld
Update in Critical Care 2007
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 808 - 819.
[Full Text] [PDF]